Doing Business In Japan

ima logo

News 23


Isogenica, based at the heart of the Cambridge UK BioMedTech cluster, has made a decisive move to open up Japan as a market for its innovative technology for antibody, protein and peptide design.

The Chesterford Research Park company has appointed CTC Laboratory Systems Corporation (CTCLS) of Tokyo to represent the business in Japan.

CTCLS is a leading force in the pharmaceutical research market in Japan and has been tasked with finding a new customer base in the territory for Isogenica.

To red the full article, please click here

Source -


Partner Profiles